Multiple studies have confirmed the superiority of ferric carboxymaltose in IBD patients compared to oral iron, demonstrating the drug to be efficacious and well-tolerated with a faster rise in Hb [55]. Here, GSTM1 is linked to inflammatory bowel disease.